Key Clinical Message
Plasmablastic lymphoma is an unusual and aggressive form of diffuse large B‐cell lymphoma, which arises more commonly within the oronasal mucosa. It should be considered as a differential diagnosis for rapidly growing periorbital lesions, particularly in the context of HIV positivity.
Keywords: HIV, orbital tumors, plasmablastic lymphoma
Case Presentation
A 45‐year‐old HIV‐positive man presented with a 2‐week history of swelling of the right lower eyelid. Magnetic resonance imaging revealed a plaque of enhancing soft tissue at the inferolateral border of the orbit (A). Incisional biopsy showed skin (B) with normal epidermis and Grenz zone (star), overlying an infiltrate of large atypical lymphoid cells (C) with mitotic figures (arrow). On immunohistochemical staining, lymphocytes were positive for MUM1 (D), CD38 (E), but negative for CD20. Ki67 proliferative index (F) and EBER in situ hybridization for Epstein–Barr virus (G) were strongly positive, signifying plasmablastic lymphoma (Fig. 1).
Figure 1.
Magnetic resonance imaging and incisional biopsy histopathology
This neoplasm, a rare and aggressive subtype of DLBCL, has more frequently been described originating from the oral and sinonasal of HIV‐positive males 1, 2, but has also been reported in immunocompetent patients 2, 3, 4. In this case, the primary lesion appears to be within the orbital mucosa. There is no standardized therapy and most published cases included systemic treatment with an individualized intensive chemotherapy regime similar to that of other lymphomas 1, 2. Prognosis is poor with an overall median survival of 8 months 5.
Our patient shows some improvement at 3 months postdiagnosis, having been commenced on cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisolone (CHOP protocol) chemotherapy.
Authorship
EB and FR: contributed to the writing and approval of the final manuscript.
Clinical Case Reports 2018; 6(1): 222–223
References
- 1. Castillo, J. J. , Bibas M., and Miranda R. N.. 2015. The biology and treatment of plasmablastic lymphoma. Blood 125:2323–2330. [DOI] [PubMed] [Google Scholar]
- 2. Mulay, K. , Ali M. J., Reddy V. A., and Honavar S. G.. 2012. Orbital plasmablastic lymphoma: a clinico‐pathological correlation of a rare disease and review of literature. Clin. Ophthalmol. 6:2049–2057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Morley, A. M. , Verity D. H., Meligonis G., and Rose G. E.. 2009. Orbital plasmablastic lymphoma – comparison of a newly reported entity with diffuse large B‐cell lymphoma of the orbit. Orbit. 28:425–429. [DOI] [PubMed] [Google Scholar]
- 4. Liu, M. , Liu B., Liu B., Wang Q., Ding L., Xia C., et al. 2015. Human immunodeficiency virus‐negative plasmablastic lymphoma: a comprehensive analysis of 114 cases. Oncol. Rep. 33:1615–1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Morscio, J. , Dierickx D., Nijs J., Verhoef G., Bittoun E., Vanoeteren X., et al. 2014. Clinicopathologic comparison of plasmablastic lymphoma in HIV‐positive, immunocompetent, and posttransplant patients: single‐center series of 25 cases and meta‐analysis of 277 reported cases. Am. J. Surg. Pathol. 38:875–886. [DOI] [PubMed] [Google Scholar]